Multimedia Supply Chain Biotech The Challenges of Choosing a CDMO or CMO Under the BIOSECURE Act The introduction of the BIOSECURE Act represents a significant shift in the landscape for pharmaceutical and biotechnology companies. This legislation ...
Blog Post Life Sciences What Does the Catalent Acquisition by Novo Holdings Mean for the Biopharma Industry? Novo Holdings, the parent company to Novo Nordisk, announced a deal this morning to acquire Catalent, a leading global CDMO ...
